As of 2026-05-27, the EV/EBITDA ratio of Kingworld Medicines Group Ltd (1110.HK) is 8.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 1110.HK's latest enterprise value is 456.77 mil HKD. 1110.HK's TTM EBITDA according to its financial statements is 56.70 mil HKD. Dividing these 2 quantities gives us the above 1110.HK EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 6.0x - 8.7x | 7.3x |
| Forward P/E multiples | 4.9x - 7.6x | 6.4x |
| Fair Price | 0.32 - 1.38 | 0.78 |
| Upside | -24.7% - 227.9% | 85.6% |
| Date | EV/EBITDA |
| 2026-05-22 | 33.96 |
| 2026-05-21 | 34.33 |
| 2026-05-20 | 34.70 |
| 2026-05-19 | 34.70 |
| 2026-05-18 | 34.70 |
| 2026-05-15 | 36.20 |
| 2026-05-14 | 36.20 |
| 2026-05-13 | 36.94 |
| 2026-05-12 | 38.43 |
| 2026-05-11 | 38.43 |
| 2026-05-08 | 38.06 |
| 2026-05-07 | 38.06 |
| 2026-05-06 | 38.06 |
| 2026-05-05 | 38.43 |
| 2026-05-04 | 38.43 |
| 2026-04-30 | 37.32 |
| 2026-04-29 | 37.69 |
| 2026-04-28 | 37.69 |
| 2026-04-27 | 39.18 |
| 2026-04-24 | 40.30 |
| 2026-04-23 | 38.81 |
| 2026-04-22 | 38.43 |
| 2026-04-21 | 39.93 |
| 2026-04-20 | 39.93 |
| 2026-04-17 | 38.81 |
| 2026-04-16 | 38.81 |
| 2026-04-15 | 39.55 |
| 2026-04-14 | 38.06 |
| 2026-04-13 | 39.18 |
| 2026-04-10 | 39.55 |
| 2026-04-09 | 40.30 |
| 2026-04-08 | 38.81 |
| 2026-04-02 | 39.18 |
| 2026-04-01 | 38.81 |
| 2026-03-31 | 40.30 |
| 2026-03-30 | 40.30 |
| 2026-03-27 | 40.30 |
| 2026-03-26 | 40.30 |
| 2026-03-25 | 41.05 |
| 2026-03-24 | 40.30 |
| 2026-03-23 | 40.30 |
| 2026-03-20 | 38.43 |
| 2026-03-19 | 39.55 |
| 2026-03-18 | 39.55 |
| 2026-03-17 | 39.55 |
| 2026-03-16 | 39.93 |
| 2026-03-13 | 41.05 |
| 2026-03-12 | 40.30 |
| 2026-03-11 | 40.30 |
| 2026-03-10 | 40.30 |